StockNasdaqGSPODD
Insulet Corporation
$135.78
-2.22 (-1.61%)today
Valuation & earnings
- P/E ratio
- 25.52
- Forward P/E
- 17.62
- EPS (ttm)
- $5.32
- Forward EPS
- $7.71
- Price/book
- 6.62
- PEG ratio
- 1.07
- Payout ratio
- 0%
Financials (ttm)
- Revenue (ttm)
- 3.1B
- Revenue growth
- 23.5%
- Profit margin
- 12.29%
- Return on equity
- 26.02%
- Total cash
- 534.9M
- Total debt
- 948.4M
Earnings (EPS)
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| Sep 30, 2025 | 1.15 | 1.24 | +8.07% |
| Dec 31, 2025 | 1.46 | 1.55 | +5.97% |
| Mar 31, 2026 | 1.19 | 1.42 | +19.26% |
| Jun 30, 2026 | 1.45 | 1.66 | +14.28% |
Next earnings date: Nov 5, 2026
Analyst view
Consensus ratingBuy25 analysts
Strong buy 4Buy 11Hold 10
12-month price targetsImplied upside: +26.61%
144
171.91
275
LowCurrent priceHigh
Latest news
(English)Insulet (PODD) Reworked Its Debt, Is The Stock Still Cheap?
Simply Wall St.Sep 25, 2026
Insulet Targets Type 2 Retention as Omnipod 6 and Global Growth Gain Momentum
MarketBeatSep 25, 2026
How Is Insulet's Stock Performance Compared to Other Medical Devices Stocks?
BarchartSep 24, 2026
BCSM Exits Insulet Corporation (PODD), Maintains Watchlist Status
Insider MonkeySep 17, 2026
2 S&P 500 Stocks with Impressive Fundamentals and 1 We Turn Down
StockStorySep 14, 2026
Why Pay More For Stryker When BSX Stock Is On Sale?
TrefisSep 14, 2026
Related products
How visible is Insulet Corporation in AI search?
We ask AI search engines about Insulet Corporation and its market — live — and measure whether and how prominently the brand appears in their answers.
No AI visibility check has been run for Insulet Corporation yet.
Run a live check to see how AI search engines talk about this brand right now.
Is your brand this visible in AI search?
Aurora tracks your brand across 7 AI search engines — visibility, share of voice and the sources that shape AI answers.